Skip to main content
MyCapitol LogoMyCapitol

· NY legislature · 2025-2026

Limits the substitution of abuse-deterrent analgesic opioid drug products for analgesic opioids lacking such technology

Provides for patient access to FDA approved abuse-deterrent technology to help combat opioid abuse.

Sponsor
Samra Brouk (D-NY)
Introduced
2025-01-08
Latest action
REFERRED TO HEALTH

Digging through Congress... 🔍